Consistent with our findings, TPX2 suppression inhibited proliferation and tumorigenicity, migration and invasion ability of CRC cells both in vitro and in vivo; mechanistically associated with AKT-mediated MMP2 activity [8]. This evidence concerns the gene TPX2 and colorectal carcinoma.